Perfuze is developing next-generation catheter-based technology to treat acute ischemic stroke, which occurs when a blood vessel in the brain is blocked by a clot, preventing blood flow

Irish medtech company Perfuze has closed a €3 million seed investment fund, with backers including Enterprise Ireland and a syndicate of Irish medical(...)

The 2018 deal values were skewered by the €54 billion approach by Japan’s Takeda Pharmaceutical for Dublin-headquartered Shire

There was a jump in mergers and acquisitions in the State last year. The value of such deals surged, new figures from Mergermarket show. The value of(...)